Castleark Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-77,132
| Closed | -$7.3M | – | 367 |
|
|
2021
Q1 | $7.3M | Buy |
77,132
+2,325
| +3% | +$220K | 0.26% | 105 |
|
|
2020
Q4 | $9.12M | Sell |
74,807
-19,491
| -21% | -$2.37M | 0.34% | 76 |
|
|
2020
Q3 | $8.24M | Sell |
94,298
-14,749
| -14% | -$1.29M | 0.32% | 92 |
|
|
2020
Q2 | $7.04M | Sell |
109,047
-970
| -0.9% | -$62.6K | 0.31% | 94 |
|
|
2020
Q1 | $4.91M | Buy |
110,017
+44,055
| +67% | +$1.97M | 0.29% | 103 |
|
|
2019
Q4 | $4.11M | Sell |
65,962
-7,404
| -10% | -$461K | 0.16% | 168 |
|
|
2019
Q3 | $2.76M | Buy |
+73,366
| New | +$2.76M | 0.11% | 193 |
|